08:36 AM EDT, 10/04/2024 (MT Newswires) -- Conmed ( CNMD ) said Friday it expects its Q3 adjusted diluted earnings per share growth to exceed its previous estimate of 9% to 11%.
Analysts polled by Capital IQ expect $0.99 per share.
Revenue for the quarter is expected to be $315 million to $318 million.
Analysts surveyed by Capital IQ expect $318.7 million.
Price: 66.69, Change: +0.13, Percent Change: +0.20